Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Starz Entertainment (STRZ) rallied sharply. The risk: a 20-30% retracement if subscriber data fails to justify the new market cap. Next earnings call is the test.
Freshpet shares fell 23.8% since February. The premium pet food brand faces consumer trade-down risk and input cost volatility. Next earnings will test demand.
MTSI $155 target from Khaveen Investments assumes a 20% CAGR from the 800G data center amplifier cycle. Cloud capex guidance decides.
Morgan Stanley sees Google, Amazon, Meta, Microsoft adding 34GW of AI compute by 2027. The forecast boosts Nvidia and custom chip demand but raises execution risk.
10-year yield hits 1-year high at 4.60%. Equities resist the spike as markets bet on growth repricing, not fiscal panic. The 4.75% level tests that story.
Trump's $1M-$5M stake in Kura Sushi sparked a rally. With an Alpha Score of 22/100, the stock's weak momentum leaves the catalyst reliant on narrative rather than fundamentals.
Gladstone Land's Q1 earnings show lease restructuring hitting the income statement. The rating upgrade on LAND signals how higher rates transmit through real-asset valuations and cash flows.
ADP's 33% sell-off compresses its premium multiple. The earnings base now faces labor market risk. Alpha Score 40 signals caution. Next catalyst: quarterly report.
Portillo's sales slide reveals how inflation damages consumer discretionary. The stock becomes a watchlist tell for Main Street pressure ahead of earnings.
Nifty 50 traders are rotating into defensives as momentum oscillators roll over and support levels fail. The next test is the 200-day moving average.
Meta Platforms Alpha Score 54/100 signals a Mixed risk/reward profile at $614.23. Traders should define the trigger that would tip the score to Bullish or Bearish before acting.
Freshworks Inc. (FRSH) published its Refresh 2026 slide deck on May 17. The presentation offers product roadmap updates. Without new guidance, the stock may trade on technicals. Watch for adoption numbers and next earnings.
The S&P 500 topping process signals failed breakouts and narrowing breadth. Long SPY or VOO? Here is what confirms a breakdown and how to manage the risk.
Analyst drops TNGX to Hold after changing combination approach for PRMT5 inhibitor vopimetostat. Strategy shift resets timeline and raises execution risk.
NVDA drops 4.4% to $225.32 ahead of May 20 earnings. Options market pricing an extreme swing; gamma exposure could amplify any move. Alpha Score 68 signals moderate fundamentals.
Nifty's 23,600 support is the key line. A break below could accelerate selling to 22,800, with banking and IT stocks most exposed. Watch for confirmation.
The S&P 500 fell 1.2% on Friday, its steepest drop since March. The index still closed a seventh straight weekly gain. The next sessions will test if the pullback resets momentum or breaks the trend.
SpaceX targets June 12 Nasdaq IPO at a $1.75 trillion valuation. Underwriters include BAC and GS. Index fast‑entry rules could drive passive demand. The prospectus is the first real test.
S&P 500 closed at 7408.50 after a gamma-driven squeeze from 6500 to 7517. The reversal is embedded in the structure. Watch 7400 support and options open interest.
Airbnb Q1 revenue rose 18% to $2.7B, beating estimates. Citizens analyst raises target to $170 on AI and loyalty. Alpha Score 36 signals mixed risk.
Applied Materials carries a valuation that assumes the AI chip equipment cycle never slows. Three risks, cyclical, trade and competitive, threaten that setup. Alpha Score 68.
Beam Global's Q1 update shows backlog growth to $9M and Q2 revenue already exceeding Q1. The EV charging and drone infrastructure play gains demand visibility.
The S&P 500's 25.9% rally has compressed implied volatility, lowering future dividends for Nuveen's SPXX. The overwrite fund now faces a double risk: capped upside and vulnerable NAV.
SpaceX targets June 12 Nasdaq debut at $1.75T valuation, raising $75B. Lead underwriters GS, JPM, BAC see modest fee boost. Exchange win for Nasdaq.
The Nasdaq's 25.9% rally from the March 30 low has pushed the index into overbought territory, creating fragile positioning that risks a sharp retracement. Here's what to watch next.
Allarity Therapeutics reported Q1 EPS -$0.17, beating by $0.05. Cash of $29.8M sets a finite runway. The stock's next move depends on pipeline progress and the 10-Q cash burn details.
iQIYI reports Q1 2026 Monday before open. Consensus loss $0.03/sh, revenue $920M. Subscriber trend and AI cost savings decide the stock's direction.
Syntec Optics' Q1 revenue of $6.5M, down 8.5% YoY, and a GAAP loss of $0.02 per share raise cash burn concerns for the micro-cap optics maker. The 10-Q filing will be the next catalyst.
MiNK Therapeutics initiates 90-patient randomized Phase II ARDS trial; initial data in 2H 2026 creates a binary catalyst for INKT stock.
Expion360 Q1 GAAP EPS -$0.17 on revenue of $1.6M, down 22% Y/Y. Cash at $3.1M. The 22% revenue drop and cash burn create a binary outcome for XPON.